Gabor Kari
GlaxoSmithKline (United States)(US)
Publications by Year
Research Areas
CAR-T cell therapy research, Immunotherapy and Immune Responses, Cancer Immunotherapy and Biomarkers, Effects of Radiation Exposure, Cell death mechanisms and regulation
Most-Cited Works
- → Zebrafish: An Emerging Model System for Human Disease and Drug Discovery(2007)464 cited
- → Antitumor Activity Associated with Prolonged Persistence of Adoptively Transferred NY-ESO-1 c259T Cells in Synovial Sarcoma(2018)419 cited
- → In vivo Radioprotection by the Fullerene Nanoparticle DF-1 as Assessed in a Zebrafish Model(2006)173 cited
- → A Novel Preclinical Strategy for Identifying Cardiotoxic Kinase Inhibitors and Mechanisms of Cardiotoxicity(2011)87 cited
- → Interaction with LC8 Is Required for Pak1 Nuclear Import and Is Indispensable for Zebrafish Development(2009)48 cited
- → Antisense inhibition of cyclin D1 expression is equivalent to flavopiridol for radiosensitization of zebrafish embryos(2006)37 cited
- → Nuclear factor κB inhibitors alleviate and the proteasome inhibitor PS-341 exacerbates radiation toxicity in zebrafish embryos(2009)34 cited
- → Protecting from R5-tropic HIV: individual and combined effectiveness of a hammerhead ribozyme and a single-chain Fv antibody that targets CCR5(2004)34 cited
- → Inhibition of p73 function by Pifithrin-α as revealed by studies in zebrafish embryos(2008)28 cited
- → Open label, non-randomized, multi-cohort pilot study of genetically engineered NY-ESO-1 specific NY-ESO-1c259t in HLA-A2+ patients with synovial sarcoma (NCT01343043).(2017)20 cited